Non-Registered Director Shin Seung-won Acquires 600 Common Shares via Open Market (0.00% Stake)
Non-registered director Shin Seung-won newly acquired 600 common shares (0.00% stake) of Samjin Pharmaceutical through open market purchases on May 14-15, 2026.
Acquisition details: 50 shares (inherited, no cost), 2 shares at 17,830 won, and 548 shares at 17,860 won, totaling 600 shares.
KOSPI Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders